glp-1 liver fibrosis Glucagon-like peptide 1 and fibroblast growth factor-21 in non-alcoholic steatohepatitis: An experimental to clinical perspective Fatty Liver Disease: How GLP-1

found that taking metformin in early pregnancy could reduce the risk of GDM (Doi et al., 2020)

GLP-1 medications act as a GLP-1 hormone (made in your small intestine) to help slow down the movement of food through your stomach while increasing the feeling of fullness so you eat less

Three biotechnical processes using Ashbya gossypii , Candida famata , or Bacillus subtilis compete with chemical riboflavin production

On June 10th, researchers from Eli Lilly published findings of a randomized phase 2a clinical trial in "Nature Medicine" titled Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. The study indicated that Retatrutide (LY3437943), a GLP-1R-related triple receptor agonist currently under clinical development, demonstrated significant efficacy and favorable safety in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD)

some people may unintentionally skip meals or eat too little during the day